Epizyme EPZM
$ 1.48
0.0%
Quarterly report 2022-Q2
added 08-09-2022
Country |
USA |
IPO year |
2013 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Robert Bazemore |
Employees in the company |
203 |
Shares |
103 M |
Market Cap[1] |
$ 249 M |
EBITDA (LTM) |
$ -196 M |
P/E (LTM) |
-0.8 |
P/S (LTM) |
4.58 |
EPS (LTM) |
-1.86 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.